KEZAR LIFE SCIENCES, INC.

Analyst Reco. Kezar Life Sciences, Inc.

Equities

KZR

US49372L1008

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
0.8547 ^USD	+1.93%		+8.19%	-9.78%

14/03	Kezar Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
14/03	Kezar Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wells Fargo Adjusts Price Target on Kezar Life Sciences to $2 From $4, Maintains Equal-Weight Rating	14/11	MT
JonesTrading Downgrades Kezar Life Sciences to Hold From Buy	05/23/05	MT
HC Wainwright Raises Kezar Life Sciences Price Target to $20 From $18, Maintains Buy Rating	25/23/25	MT
Wells Fargo Downgrades Kezar Life Sciences to Equalweight From Overweight	11/23/11	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $18 From $19, Maintains Buy Rating	11/23/11	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $19 From $21, Keeps Buy Rating	12/23/12	MT
Wells Fargo Trims Kezar Life Sciences Price Target to $13 From $14, Maintains Overweight Rating	12/23/12	MT
William Blair Downgrades Kezar Life Sciences to Market Perform From Outperform	16/23/16	MT
Wells Fargo Cuts Price Target on Kezar Life Sciences to $14 From $17, Maintains Overweight Rating	03/23/03	MT
Wells Fargo Adjusts Kezar Life Sciences Price Target to $17 From $13, Maintains Overweight Rating	28/22/28	MT
Wells Fargo Adjusts Kezar Life Sciences' Price Target to $14 from $19, Keeps Overweight Rating	04/22/04	MT
Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services Index	04/22/04	MT
HC Wainwright Adjusts Kezar Life Sciences' Price Target to $22 From $20, Keeps Buy Rating	18/22/18	MT
Wells Fargo Starts Kezar Life Sciences at Overweight With $19 Price Target	08/21/08	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $20 from $12, Keeps Buy Rating	16/21/16	MT
KEZAR LIFE SCIENCES : JonesTrading Starts Kezar Life Sciences at Buy With $14 Price Target	20/21/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer